When was AccuPulse founded?

AccuPulse was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is AccuPulse located?

AccuPulse is headquartered in Suzhou, China.

How many employees does AccuPulse have?

As of Jul 31, 2026, the latest employee count at AccuPulse is 24.

Is AccuPulse a funded company?

AccuPulse is a funded company, having raised a total of $18M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 2021.

When was the latest funding round of AccuPulse?

AccuPulse's latest funding was a $***** Series A round on May 25, 2022, with participation from 2 investors. Its primary sector is Cardiac and Vascular Disorders. In China, the Cardiac and Vascular Disorders sector has seen $73.4M in funding in 2026 to date.

Where does AccuPulse rank among its competitors?

AccuPulse ranks 13th amongst 19 active competitors, of which 12 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Pulsecare Medical Technology, which secured $14M in Nov, 2025.

Who are the top competitors of AccuPulse?

AccuPulse's top competitors include Kardium, Galvanize and Field Medical. Among them, Pulsecare Medical Technology secured the most recent funding round in November, 2025.

AccuPulse - 2026 Company Profile, Funding & Competitors

Company Details

Manufacturer of pulsed electric field ablation generators and cardiac catheters. Development efforts focus on hardware for treating cardiac arrhythmias through interventional therapy. Systems include navigation components for mapping signal acquisition and catheter localization during medical procedures.

Website: accupulse.com
Email ID: *****@accupulse.com

Key Metrics

Founded Year

2020

Location

Suzhou, China

Stage

Series A

Total Funding

$18M in 2 rounds

Latest Funding Round

Series A, May 25, 2022, $*****

Investors

SZQH & 1 more

Ranked

13^th among 19 active competitors

Employee Count

24 as on Jul 31, 2026

Similar Companies

Kardium & 17 more

View AccuPulse's full profile

AccuPulse has raised a total funding of $18M over 2 rounds. Its first funding round was on Nov 2021. Its latest funding round was a Series A round on May 25, 2022 for $*****. 2 investors participated in its latest round. AccuPulse has 2 institutional investors.

Here is the list of recent funding rounds of AccuPulse:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 25, 2022	5459335	Series A	8260987	5343454	2573164	1462832
Nov 2021	1772165	Seed	2627504	3114697	4423721	6902443

Access funding benchmarks and valuations. Sign up today!

View details of AccuPulse's funding rounds and investors

AccuPulse's employee count trend

AccuPulse has 24 employees as of Jul 26. Here is AccuPulse's employee count trend over the years:

Uncover AccuPulse's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AccuPulse include Kardium, Galvanize and Field Medical. Here is the list of Top 10 competitors of AccuPulse, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kardium 2007, Burnaby (Canada), Series C	Developer of ablation device for atrial fibrillation	$471M	Fidelity Investments, T. Rowe Price & 10 others	65/100
2nd	Galvanize 2020, San Carlos (United States), Series C	Developer of pulsed electric field systems for various medical indications	$210M	Fidelity Investments, Sofinnova Partners ... & 11 others	58/100
3rd	Field Medical 2022, Encinitas (United States), Series B	Developer of device for the treatment of heart arrhythmia conditions	$89M	BioStar Capital, Cue Growth Partners	56/100
4th	Pulse Biosciences 2014, Burlingame (United States), Acquired	Developer of a platform technology called Nano-Pulse Electro-Signaling	$8M	MDB Capital, Sea Purity Investments & 1 others	50/100
5th	Pulsecare Medical Technology 2021, Shenzhen (China), Series A	Developer of medical device solutions for heart and vascular care	$14M	Oriza Holdings, Loayal Valley Capital & 3 others	50/100
6th	Affera 2014, Boston (United States), Acquired	Developer of devices to treat heart rhythm disorders	-	Innogest Capital, Bain Capital Life Sciences ... & 4 others	47/100
7th	Argá Medtech 2020, Epalinges (Switzerland), Series B	Developer of medical devices for treating cardiac arrhythmias	$58.5M	Advent Life Sciences, Earlybird & 1 others	45/100
8th	Farapulse 2014, Menlo Park (United States), Series C	Advanced cardiac ablation solutions for atrial fibrillation treatment	$36.3M	F-Prime Capital, Boston Scientific & 3 others	42/100
9th	EnChannel Medical 2020, Ladera Ranch (United States), Series B	Developer of medical device for cardiac disorders	$110M	LAV, DragonBall Capital & 2 others	39/100
10th	AtriAN 2017, Galway (Ireland), Seed	Developing the device that targets to atrial fibrillation	$2.56M	Western Development Commission, Mayo Clinic Ventures ... & 4 others	34/100
13th	AccuPulse 2020, Suzhou (China), Series A	Manufacturer of pulsed electric field ablation generators and cardiac catheters	$18M	Yuanbio Venture Capital, SZQH	30/100